Targeted nanoparticle contrast agents for vascular molecular imaging and therapy

Keyphrases

• Magnetic Resonance Imaging 100%
• Molecular Imaging 100%
• Molecular Imaging Agents 100%
• Molecular Therapy 100%
• Targeted Nanoparticles 100%
• Nanoparticle Contrast Agents 100%
• Liposomes 66%
• Dendrimer 66%
• Nanotechnology 66%
• Emulsion 66%
• Binding Site 33%
• Clinical Opportunities 33%
• Computed Tomography 33%
• Multilamellar Vesicles 33%
• High-density Lipoprotein Cholesterol (HDL-C) 33%
• Imaging Agents 33%
• Size-and-shape 33%
• Surfactant 33%
• Imaging Tomography 33%
• Drug Efficacy 33%
• Ultrasonic Resonance 33%
• Drug Delivery 33%
• Doxorubicin 33%
• Globular 33%
• Perfluorocarbon 33%
• Molecular Assembly 33%
• Nanoparticulate System 33%
• Targeting Ligands 33%
• Imaging Ultrasound 33%
• Individual Cells 33%
• Drug Safety 33%
• Bilayer Lipid Membrane 33%
• Functional Site 33%
• Gadolinium Complex 33%
• Multivalent 33%
• Signal Enhancement 33%
• Copolymer 33%
• Highly Branched 33%
• Liposomal 33%
• Oilfield Produced Water 33%
• Therapeutic Delivery 33%
• Fluorescence Molecular Tomography 33%
• Low-density Lipoprotein Particle 33%
• Ultrasound Tomography 33%
• Local Drug Delivery 33%
• Polylactic Acid 33%
• Macromolecular Drugs 33%
• Nanometer-sized 33%
• Polyamidoamine (PAMAM) 33%
• Polymer Nanoparticles 33%
• Drug Imaging 33%
• Water Type 33%
• Polymeric Structure 33%
• Doxil 33%
• Emulsion Particle 33%
• Poly(d,l-lactide-co-glycolide) 33%
• 1,4-diaminobutane 33%
• Agent Delivery 33%
• Polyhydroxy Acids 33%
• Localized Gene Delivery 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Liposome 100%
• Nanoparticle 100%
• Dendrimer 100%
• Contrast Medium 100%
• Doxorubicin 100%
• Gene Delivery 50%
• Lipoprotein 50%
• Binding Site 50%
• Surfactant 50%
• Fluorocarbon 50%
• Gadolinium 50%
• Low Density Lipoprotein 50%
• Copolymer 50%
• Poly(amidoamine) 50%
• Polylactic Acid 50%